Novartis Bioventures Ltd Aileron Therapeutics Inc (ALRN) insider trading activity

Novartis Bioventures LTD is > 10% Shareholder of AILERON THERAPEUTICS INC. Currently has a direct ownership of 2.08 Million shares of ALRN, which is worth approximately $6.36 Million. The most recent transaction as insider was on Jul 17, 2018, when has been sold 12,500 shares (Common Stock) at a price of $4.71 per share, resulting in proceeds of $58,875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.08M

0% 3M change

0% 12M change

Total Value Held $6.36 Million

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2018	SELL Open market or private sale	$58,875 $4.71 p/Share	12,500 Reduced 0.49%	2,531,382 Common Stock
Jul 16 2018	SELL Open market or private sale	$1,545 $5.15 p/Share	300 Reduced 0.01%	2,543,882 Common Stock
Jul 05 2017	BUY Open market or private purchase	$4,000,005 $15.0 p/Share	266,667 Added 9.49%	2,544,182 Common Stock
Jul 05 2017	BUY Conversion of derivative security	-	2,277,515 Added 50.0%	2,277,515 Common Stock

Also insider at

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

GRTX

Galera Therapeutics, Inc. Healthcare

AKUS

Akouos, Inc. Healthcare

NBL